BRIDGET EVANS: Open Payments
NPI 1841643525 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,065 in 56 payments from 15 companies in 2025. Trend: 2023 $152 · 2024 $2,105 · 2025 $1,065
Food & beverage: $1,005Education: $60
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 20 | $267 |
| ABBVIE INC. | 9 | $151 |
| Mallinckrodt Hospital Products Inc. | 4 | $142 |
| UCB, Inc. | 3 | $105 |
| PFIZER INC. | 4 | $90 |
| E.R. Squibb & Sons, L.L.C. | 4 | $79 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| GENZYME CORPORATION | 2 | $41 |
| Alexion Pharmaceuticals, Inc. | 1 | $30 |
| Aurinia Pharma U.S., Inc. | 1 | $26 |
Products named: ACTHAR, ENBREL, Bimzelx, RINVOQ, XELJANZ, TAVNEOS, ORENCIA, BENLYSTA.
Industry payments across KY — which companies pay providers there.
